USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Emerging Therapeutic Platforms and AI-driven Innovations in Biologics, Oncology, and Precision Medicine
Life Science, Health & Wellness Technology Opportunity Engine
14-Nov-2025
Global
Technology Research
D759-00-4M-00-00
HC_2025_34095
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides actionable insights across new developments in oncology, immunology, autoimmune disorders, and precision medicine, highlighting next-generation biologics, bispecific antibodies, kinase inhibitors, molecular glues, and antibody engineering platforms. The TOE also features advances in AI- and ML-driven drug discovery, proteomic analytics, and digital health innovations enabling targeted and personalized therapies.
The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Therapeutic Antibody to Deplete Pro-inflammatory Cytokines to Treat Autoimmune and Inflammatory Diseases
Therapeutic Antibody Targeting IL-4 Receptor-α to Treat Seasonal Allergic Rhinitis
Allosteric BCR-ABL Inhibitor to Treat Chronic Myeloid Leukaemia
AI-driven virtual care coordination platform
AI-driven Patient-facing Digital Concierge for Streamlined Care Co-ordination
Half-life Extended IL-23p19 Antibody For Psoriasis Treatment
Robotic Capsule Enabling Delivery Of Biologics
Best-in-class Bispecific Antibodies To Target Ophthalmic Diseases With Unmet Need
Next-Gen Oral URAT1 Inhibitor As A Second Line Of Treatment To Transform Gout Therapy
Non-protein Degraders To Address Previously Undruggable Disease Targets
Microscopic DNA Flower To Enable Targeted Delivery Of Drugs
Speak directly with our analytics experts for tailored recommendations.
Recent related In Vitro Diagnostics (IVD) research
21 Jul 2026 | Global | Market Research
Point-of-Care Testing Market, Global, 2024–2031
The global POCT market is rapidly evolving from standalone rapid diagnostics to connected, AI-enabled clinical intelligence ecosystems that support decentralized healthcare delivery. Growth is driven by the increasing demand for faster clinical decision-making, early disease detection, personalized ...
17 Jul 2026 | Global | Technology Research
Innovations and Growth Opportunities in AI-Driven Drug Discovery, Precision Diagnostics, Advanced Biologics, and Next-generation Vaccines
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and autoimmune disorders, metabolic and age...
08 Jul 2026 | Global | Technology Research
Precision Obesity Management: AI-Guided Metabolic Modulation
The report explores the transformation of obesity care from generalized BMI-based treatment to AI-enabled precision metabolic management. The study highlights how obesity is increasingly recognized as a heterogeneous, multi-pathway disease influenced by genetic, neurobehavioral, metabolic, and envir...
25 Jun 2026 | Global | Technology Research
Quantum Sensors Transitioning from Lab to Industry: Ultra-Precision Measurement for Healthcare, Defense, and Manufacturing
Quantum sensing is transitioning from laboratory research to industrial deployment, driven by the need for ultra-precise, reliable measurement in high-impact sectors such as healthcare, defense, and advanced manufacturing. This shift reflects a broader move from controlled, research-grade environmen...
22 Jun 2026 | Global | Market Research
Growth Opportunities, Global Life Sciences LIMS Market, Forecast to 2031
The global life sciences laboratory information management systems (LIMS) industry is forecast to grow from 2026 to 2031 at a CAGR of 8.5%, driven by the increasing need for laboratory automation, regulatory compliance, and cloud-based solutions.
Leading players in the global life sciences L...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
| Deliverable Type | Technology Research |
|---|---|
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | therapeutic platforms market |
| Keyword 2 | precision medicine market |
| Keyword 3 | biologics innovation |
| Podcast | No |
| Predecessor | D759-00-4L-00-00 |
| WIP Number | D759-00-4M-00-00 |